Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	899	1,120	173	378	468	594
Market Cap Growth	432.76%	547.12%	-54.25%	-19.06%	-21.26%	-48.75%
Enterprise Value	419	1,104	-59	136	368	409
PE Ratio	-	-5.38	-1.16	-2.66	-3.29	-4.79
PS Ratio	85.66	659.89	27.23	162.43	272.63	204.18
PB Ratio	1.54	10.05	0.58	1.21	2.23	2.33
P/FCF Ratio	-11.19	-7.16	-1.41	-2.99	-3.53	-4.96
P/OCF Ratio	-11.81	-7.70	-1.54	-3.21	-3.97	-5.85
EV/Sales Ratio	39.96	650.19	-9.35	58.28	214.36	140.49
EV/EBITDA Ratio	-8.32	-7.23	0.46	-1.05	-2.29	-3.04
EV/EBIT Ratio	-7.71	-6.76	0.43	-0.96	-2.21	-2.94
EV/FCF Ratio	-8.03	-7.05	0.48	-1.07	-2.78	-3.41
Debt / Equity Ratio	0.48	2.01	0.50	0.22	0.26	0.10
Debt / EBITDA Ratio	-1.91	-1.47	-1.17	-0.53	-0.34	-0.20
Debt / FCF Ratio	-1.85	-1.43	-1.22	-0.54	-0.41	-0.22
Quick Ratio	17.27	5.37	8.26	10.88	4.58	8.46
Current Ratio	18.29	6.15	9.18	12.15	5.86	9.98
Asset Turnover	0.02	0.00	0.02	0.01	0.01	0.01
Interest Coverage	-2.66	-3.62	-15.68	-127.54	-	-
Return on Equity (ROE)	-80.20%	-105.70%	-63.00%	-49.80%	-57.20%	-47.60%
Return on Assets (ROA)	-41.50%	-49.30%	-41.60%	-41.10%	-45.10%	-40.30%
Return on Capital (ROIC)	-20.35%	-53.59%	-31.95%	-36.99%	-63.64%	-51.97%
Earnings Yield	-24.61%	-18.60%	-85.96%	-37.55%	-30.39%	-20.86%
FCF Yield	-16.86%	-13.97%	-71.12%	-33.48%	-28.33%	-20.18%
Buyback Yield / Dilution	-27.81%	-83.11%	-31.78%	-39.81%	-19.72%	-36.47%
Total Shareholder Return	-27.81%	-83.11%	-31.78%	-39.81%	-19.72%	-36.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).